e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Clinical management of orphan lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Different disease subtypes in allergic eosinophilic granulomatosis with polyangiitis (EGPA)
M. Latorre, F. Novelli, C. Baldini, E. Bacci, V. Seccia, S. Cianchetti, S. Bombardieri, P. L. Paggiaro (Pisa, Italy)
Source:
Annual Congress 2013 –Clinical management of orphan lung diseases
Session:
Clinical management of orphan lung diseases
Session type:
Oral Presentation
Number:
1797
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Latorre, F. Novelli, C. Baldini, E. Bacci, V. Seccia, S. Cianchetti, S. Bombardieri, P. L. Paggiaro (Pisa, Italy). Different disease subtypes in allergic eosinophilic granulomatosis with polyangiitis (EGPA). Eur Respir J 2013; 42: Suppl. 57, 1797
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials
Related content which might interest you:
Asthma follow-up and treatment in a group of 28 patients with eosinophilic granulomatosis with polyangiitis (EGPA)
Source: Annual Congress 2013 –Is it really asthma?
Year: 2013
Co-existence of eosinophilic granulomatosis with polyangiitis, HIV and HCV infection: A rare coincidence?
Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects
Year: 2015
Chronic nasal inflammation in asthmatic patients with eosinophilic granulomatosis with polyangitis (EGPA)
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014
Nasal disease in chronic severe asthma (CSA) and eosinophilic granulomatosis with poliangiitis (EGPA)
Source: International Congress 2015 – Co-existing diseases and asthma
Year: 2015
ANCA-negative eosinophilic granulomatosis with polyangiitis (EGPA) relatead to sirolimus-eluting stent
Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects
Year: 2015
Secondary organizing pneumonia (BOOP)-associated with granulomatosis with polyangiitis [Wegener granulomatosis (WG)]: A clinicoradiological study of 19 cases
Source: International Congress 2014 – ILDs 6
Year: 2014
New biomarkers for early diagnosis of eosinophilic granulomatosis with polyangiitis (EGPA)
Source: International Congress 2017 – Techniques to treat asthma
Year: 2017
Cognitive impairment in patients with eosinophilic granulomatosis with polyangiitis (EGPA): Service evaluation in a regional severe asthma centre in North-west England
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016
Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg–Strauss)
Source: Eur Respir J 2016; 48: 1429-1441
Year: 2016
Frequency of eosinophilic granulomatosis with polyangiitis in Europe by meta-analysis
Source: Virtual Congress 2020 – Prevalence and incidence of chronic lung diseases
Year: 2020
An atypical presentation of granulomatosis with polyangiitis (GPA) with pituitary involvement
Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice
Year: 2015
Granulomatosis with polyangiitis (Wegener&s)
Source: Eur Respir Mon 2011; 54: 1-14
Year: 2011
Biologics for eosinophilic granulomatosis with polyangiitis
Source: Short video statement 2020
Year: 2020
Classification and new developments in the pathogenesis of vasculitis
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=50
Year: 2005
Eosinophilic granulomatosis with polyangiitis (formerly Churg–Strauss syndrome): where are we now?
Source: Eur Respir J 2015; 46: 1255-1258
Year: 2015
Neutrophil chemotaxis in granulomatosis with polyangiitis (Wegener’s) and idiopathic pulmonary fibrosis
Source: Eur Respir J 2011; 38: 1081-1088
Year: 2011
Clinical manifestation, approach to diagnosis and treatment of pulmonary vasculitis
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=69
Year: 2005
Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis
Source: ERJ Open Res, 6 (4) 00451-2020; 10.1183/23120541.00451-2020
Year: 2020
Coexistent granulomatosis with polyangiitis (Wegener‘s) and Crohn disease: A clinicopathologic description of cases
Source: Annual Congress 2012 - Pulmonary manifestations of systemic diseases
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept